Some history and context regarding the CBD and ABS

It is very helpful to understand the broader context of why we have ended up in this situation with regard to the CBD, ABS, Nagoya, ITPGRFA, et al. Sabrina Safrin, an international lawyer who participated in the negotiations for the "International Treaty on Plant Genetic Resources for Food and Agriculture" (ITPGRFA) and presented a very well-received talk in a symposium at the 2008 APGA meeting, wrote an excellent award-winning article about the situation:

"Hyperownership in a Time of Biotechnological Promise: The International Conflict to Control the Building Blocks of Life"

How do we best document & manage plants to ensure compliance with CBD? How should gardens treat plants obtained prior to 1993 before CBD came into force? What should gardens do with plants obtained since 1993 which are not in compliance?

What are best practices when using plants covered by CBD for plant breeding, plant sales, and other commercial uses? Should these also apply to plant societies and others using public gardens for their activities? What about wild origin plants obtained from commercial sources?